X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-11-19 | BLFS | Biolife Solutions Inc | Duross Amy | Dir | S - Sale | $24.76 | -6,000 | 24,687 | -20% | -$148,545 | |||||
2025-11-19 | MDT | Medtronic Plc | Smith Gregory L | EVP Global Ops, Supply Chain | S - Sale | $101.95 | -30,000 | 46,016 | -39% | -$3,058,451 | ||||||
2025-11-21 | STEX | Streamex Corp. | Lekstrom Morgan Lee | Dir | P - Purchase | $3.58 | +7,000 | 7,000 | New | +$25,060 | ||||||
2025-11-20 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.96 | +5,760 | 88,736 | +7% | +$5,530 | ||||||
2025-11-19 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.96 | +1,000 | 82,976 | +1% | +$960 | ||||||
2025-11-19 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.08 | -1,405 | 379,657 | 0% | -$1,517 | ||||||
2025-11-18 | LIVN | Livanova Plc | Story Brooke | Dir | S - Sale | $53.94 | -250 | 6,232 | -4% | -$13,485 | ||||||
2025-11-18 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.94 | +2,133 | 81,976 | +3% | +$2,005 | ||||||
2025-11-17 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $4.60 | -916 | 163,662 | -1% | -$4,214 | ||||||
2025-11-17 | OM | Outset Medical, Inc. | Nash Marc | EVP Operations R, D, Service | S - Sale | $4.60 | -247 | 48,268 | -1% | -$1,136 | ||||||
2025-11-17 | TMDX | Transmedics Group, Inc. | Hassanein Waleed H | Pres, CEO | P - Purchase | $114.00 | +8,775 | 616,433 | +1% | +$1,000,350 | ||||||
2025-11-17 | OM | Outset Medical, Inc. | Brottem John L. | GC | S - Sale | $4.60 | -388 | 46,495 | -1% | -$1,785 | ||||||
| D | 2025-11-17 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO, interim CFO, Dir | S - Sale+OE | $20.21 | -70,406 | 241,303 | -23% | -$1,422,608 | |||||
| M | 2025-11-14 | STXS | Stereotaxis, Inc. | Isaac Paul J | See Remarks | P - Purchase | $2.22 | +30,000 | 2,883,856 | +1% | +$66,600 | |||||
| M | 2025-11-14 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $0.97 | +50,000 | 350,000 | +17% | +$48,332 | |||||
2025-11-17 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.96 | +3,124 | 79,843 | +4% | +$2,999 | ||||||
2025-11-14 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $0.88 | +14,769 | 76,719 | +24% | +$12,997 | ||||||
2025-11-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,764 | 27,887,779 | +7% | +$1,983,333 | ||||||
2025-11-12 | ECOR | Electrocore, Inc. | Lev Joshua S. | CFO | S - Sale | $6.18 | -2,166 | 23,667 | -8% | -$13,386 | ||||||
| M | 2025-11-11 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $25.80 | -100,000 | 389,998 | -20% | -$2,580,422 | |||||
| DM | 2025-11-10 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale+OE | $24.01 | -22,818 | 100 | -100% | -$547,889 | |||||
2025-11-12 | ITGR | Integer Holdings Corp | Harris John A | EVP, Global Ops, Manufactur | P - Purchase | $70.00 | +1,650 | 6,066 | +37% | +$115,500 | ||||||
| D | 2025-11-11 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $12.28 | -11,112 | 167,704 | -6% | -$136,455 | |||||
2025-11-11 | ITGR | Integer Holdings Corp | Thomas Tommy P | VP, Corporate Controller | S - Sale | $70.15 | -884 | 3,596 | -20% | -$62,013 | ||||||
2025-11-07 | ITGR | Integer Holdings Corp | Smith Diron | EVP, Chief Financial Officer | P - Purchase | $67.19 | +1,116 | 7,698 | +17% | +$74,967 | ||||||
2025-11-06 | ITGR | Integer Holdings Corp | Capps Cheryl C | Dir | P - Purchase | $66.70 | +1,600 | 11,702 | +16% | +$106,720 | ||||||
| DM | 2025-11-05 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale+OE | $24.04 | -16,778 | 100 | -99% | -$403,263 | |||||
2025-11-06 | CNMD | Conmed Corp | Garner Todd W | EVP, CFO | S - Sale | $43.00 | -3,500 | 1,836 | -66% | -$150,500 | ||||||
| D | 2025-10-29 | TMDX | Transmedics Group, Inc. | Basile Edward M | Dir | S - Sale+OE | $130.45 | -4,142 | 2,866 | -59% | -$540,324 | |||||
| DM | 2025-10-29 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale+OE | $21.32 | -58,483 | 100 | -100% | -$1,246,717 | |||||
2025-10-30 | ITGR | Integer Holdings Corp | Khales Payman | Pres, CEO | P - Purchase | $64.94 | +3,127 | 22,865 | +16% | +$203,067 | ||||||
2025-10-24 | BLFS | Biolife Solutions Inc | Goswami Joydeep | Dir | S - Sale | $28.99 | -1,666 | 44,986 | -4% | -$48,297 | ||||||
2025-10-27 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.62 | +3,703,703 | 26,150,015 | +17% | +$5,999,999 | ||||||
2025-10-22 | BLFS | Biolife Solutions Inc | De Greef Roderick | Pres, CEO | S - Sale | $27.30 | -37,795 | 489,998 | -7% | -$1,031,804 | ||||||
2025-10-22 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale | $18.02 | -1,457 | 100 | -94% | -$26,252 | ||||||
2025-10-20 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $27.82 | -275 | 26,037 | -1% | -$7,651 | ||||||
2025-10-16 | BLFS | Biolife Solutions Inc | Goswami Joydeep | Dir | S - Sale | $0.00 | -1,334 | 46,652 | -3% | -$0 | ||||||
2025-10-15 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $28.55 | -750,000 | 5,957,165 | -11% | -$21,410,325 | ||||||
2025-10-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.14 | +1,737,764 | 22,446,312 | +8% | +$1,983,333 | ||||||
2025-10-09 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $27.36 | -833 | 183,353 | 0% | -$22,791 | ||||||
2025-10-09 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $27.36 | -289 | 133,617 | 0% | -$7,907 | ||||||
2025-10-09 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $27.36 | -509 | 350,912 | 0% | -$13,926 | ||||||
2025-10-09 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $27.36 | -188 | 77,169 | 0% | -$5,144 | ||||||
2025-10-09 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $27.36 | -419 | 193,253 | 0% | -$11,464 | ||||||
| D | 2025-10-03 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $12.54 | -11,112 | 167,704 | -6% | -$139,344 | |||||
2025-10-06 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale | $18.00 | -736 | 1,557 | -32% | -$13,249 | ||||||
| M | 2025-10-02 | AXGN | Axogen, Inc. | Burke William P. Mr. | Dir | S - Sale | $18.14 | -32,191 | 2,293 | -93% | -$584,074 | |||||
2025-09-15 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $25.61 | -714 | 77,357 | -1% | -$18,286 | ||||||
2025-09-15 | VANI | Vivani Medical, Inc. | Williams Gregg | Dir, 10% | P - Purchase | $1.16 | +2,068,453 | 20,708,548 | +11% | +$2,400,001 | ||||||
2025-09-16 | AXGN | Axogen, Inc. | Devinney Erick Wayne | Chief Innovation Officer | S - Sale | $16.29 | -1,137 | 220,649 | -1% | -$18,522 | ||||||
| M | 2025-07-25 | STEX | Streamex Corp. | Giustra Frank | 10% | P - Purchase | $4.12 | +178,205 | 178,205 | New | +$734,725 | |||||
2025-09-11 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $26.83 | -511 | 193,672 | 0% | -$13,710 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $26.83 | -630 | 351,421 | 0% | -$16,903 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $26.83 | -1,032 | 184,186 | -1% | -$27,689 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $26.83 | -358 | 133,906 | 0% | -$9,605 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $26.83 | -233 | 78,071 | 0% | -$6,251 | ||||||
2025-09-11 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $26.83 | -72 | 26,312 | 0% | -$1,932 | ||||||
2025-09-12 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +1,450 | 61,950 | +2% | +$1,975 | ||||||
2025-09-12 | CNMD | Conmed Corp | Farkas Charles | Dir | S - Sale | $53.52 | -2,000 | 14,859 | -12% | -$107,049 | ||||||
| M | 2025-09-10 | ELMD | Electromed, Inc. | Summers Andrew | Dir | S - Sale | $24.32 | -65,714 | 282,420 | -19% | -$1,598,454 | |||||
2025-09-11 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,250 | 60,500 | +2% | +$1,682 | ||||||
2025-09-10 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.34 | +1,500 | 59,250 | +3% | +$2,010 | ||||||
2025-09-09 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.37 | +1,500 | 57,750 | +3% | +$2,055 | ||||||
2025-09-08 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.40 | +500 | 56,250 | +1% | +$700 | ||||||
| D | 2025-09-04 | CBLL | Ceribell, Inc. | Woo Raymond | CTO | S - Sale+OE | $12.11 | -11,112 | 167,704 | -6% | -$134,566 | |||||
2025-09-05 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,000 | 55,750 | +2% | +$1,350 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | Grujic Alan | Dir | P - Purchase | $0.00 | +152,108 | 1,817,541 | +9% | +$0 | |||||
2025-09-03 | MDT | Medtronic Plc | Kiil Harry Skip | EVP, Pres Cardiovascular | S - Sale | $91.58 | -8,605 | 35,615 | -19% | -$788,048 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | Imhoff John E | Dir, 10% | P - Purchase | $0.18 | +166,667 | 19,463,595 | +1% | +$30,000 | |||||
2025-09-03 | CBLL | Ceribell, Inc. | Robertson Rebecca B | Dir | S - Sale | $11.36 | -827 | 9,215 | -8% | -$9,395 | ||||||
| D | 2025-08-29 | GTHP | Guided Therapeutics Inc | James Michael C | Dir | P - Purchase | $0.18 | +27,778 | 553,495 | +5% | +$5,000 | |||||
2025-09-04 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +1,125 | 54,750 | +2% | +$1,531 | ||||||
2025-09-03 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.36 | +625 | 53,625 | +1% | +$850 | ||||||
2025-09-02 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.34 | +625 | 53,000 | +1% | +$838 | ||||||
2025-08-29 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.37 | +625 | 52,375 | +1% | +$856 | ||||||
2025-08-27 | CBLL | Ceribell, Inc. | Foehr David | SVP, Finance, PAO | S - Sale | $11.71 | -866 | 20,250 | -4% | -$10,141 | ||||||
2025-08-28 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.35 | +1,005 | 51,750 | +2% | +$1,356 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Mathew Aby J. | EVP, Chief Scientific Officer | S - Sale | $25.44 | -531 | 352,051 | 0% | -$13,509 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Foster Karen A. | Chief Quality, Operations | S - Sale | $25.44 | -413 | 194,183 | 0% | -$10,507 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Werner Sean | CTO | S - Sale | $25.44 | -111 | 26,384 | 0% | -$2,824 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Wichterman Troy | CFO | S - Sale | $25.44 | -590 | 185,218 | 0% | -$15,010 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Aebersold Sarah | CHRO | S - Sale | $25.44 | -219 | 78,304 | 0% | -$5,571 | ||||||
2025-08-26 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.44 | -354 | 134,264 | 0% | -$9,006 | ||||||
2025-08-27 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.28 | +1,000 | 50,745 | +2% | +$1,283 | ||||||
2025-08-25 | BLFS | Biolife Solutions Inc | Berard Todd | CMO | S - Sale | $25.53 | -10,000 | 124,618 | -7% | -$255,300 | ||||||
2025-08-25 | LIVN | Livanova Plc | Bianchi Francesco | Dir | S - Sale | $56.50 | -1,500 | 9,028 | -14% | -$84,750 | ||||||
2025-08-26 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.26 | +1,000 | 49,745 | +2% | +$1,258 | ||||||
| D | 2025-08-25 | SMLR | Semler Scientific, Inc. | Murphy-Chutorian Douglas | CEO | S - Sale+OE | $30.54 | -28,604 | 186,709 | -13% | -$873,566 | |||||
2025-08-25 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.25 | +1,000 | 48,745 | +2% | +$1,245 | ||||||
| M | 2025-08-22 | MDT | Medtronic Plc | Jellison William R | Dir | P - Purchase | $92.55 | +5,000 | 5,000 | New | +$462,750 | |||||
2025-08-22 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.22 | +1,000 | 47,745 | +2% | +$1,220 | ||||||
2025-08-21 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.25 | +2,000 | 46,745 | +4% | +$2,490 | ||||||
2025-08-15 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $24.40 | -500,000 | 6,707,165 | -7% | -$12,200,000 | ||||||
2025-08-19 | CBLL | Ceribell, Inc. | Taylor Joseph Michael | Dir | S - Sale | $11.76 | -7,032 | 59,235 | -11% | -$82,696 | ||||||
2025-08-20 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.18 | +1,000 | 44,745 | +2% | +$1,184 | ||||||
2025-08-19 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.17 | +3,000 | 43,745 | +7% | +$3,499 | ||||||
2025-08-18 | IRIX | Iridex Corp | Moore William M | Dir | P - Purchase | $1.18 | +12,024 | 300,000 | +4% | +$14,229 | ||||||
2025-08-18 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.18 | +1,500 | 40,745 | +4% | +$1,767 | ||||||
2025-08-15 | IRIX | Iridex Corp | Dizon Romeo R | CFO | P - Purchase | $1.17 | +1,500 | 39,245 | +4% | +$1,755 | ||||||
2025-08-18 | HYPR | Hyperfine, Inc. | Teisseyre Thomas | COO | S - Sale | $1.33 | -1,151 | 381,062 | 0% | -$1,531 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |